Legal Representation
Attorney
Karen L. Elbing
USPTO Deadlines
Next Deadline
2170 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 13, 2032
Grace Period Ends
July 13, 2032
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 13, 2026 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 13, 2026 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 27, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 27, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 27, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 27, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 27, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 23, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 23, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 23, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 26, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 26, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 26, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 2, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 2, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 2, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 27, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 19, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 26, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Nucleic acid sequences, other than for medical or veterinary purposes; artificial nucleic acid sequences, other than for medical or veterinary purposes; amino acid sequences, other than for medical or veterinary purposes; artificial amino acid sequences, other than for medical or veterinary purposes; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial use, other than for medical or veterinary purposes; biopolymers, namely, unprocessed polymers of amino acids and hydroxy acids; biopolymers, namely, unprocessed polymers of amino acids; biopolymers, namely, unprocessed polymers of hydroxy acids; biomolecules, namely amino acids, other than for medical or veterinary purposes; biomolecules, namely hydroxy acids, other than for medical or veterinary purposes; biomolecules, namely amino acids and hydroxy acids, other than for medical or veterinary purposes; bioplastics in the nature of unprocessed plastics that derive from biological sources; synthetic bacteria for use in the manufacture of polymers and materials comprising amino acids; synthetic bacteria for use in the manufacture of polymers and materials comprising hydroxy acids; synthetic bacteria for use in the manufacture of polymers and materials comprising nucleic acid sequences; recoded bacterial genomes, namely, nucleic acid sequences with a modified genetic code that differs from the genetic code of the native species, other than for medical or veterinary purposes; synthetic eukaryotic cells in the nature of mammalian, plant, yeast or other eukaryotic cells with a synthetic genome for scientific, laboratory or medical research; recoded eukaryotic genomes namely, nucleic acid sequences with a modified genetic code that differs from that of the native species, other than for medical or veterinary purposes; reagents for research purposes; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising amino acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising hydroxy acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising nucleic acid sequences; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for scientific purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for scientific purposes
Class 005
Pharmaceuticals preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; biotechnological preparations for medical and veterinary use, namely, biotechnological pharmaceutical preparations in the form of fluid extracts for medicinal uses, pills, medicated tablets, compressed medicinal lozenges, elixirs, syrups for medicinal preparations, medicinal cordials, solid extracts, powdered extracts, concentrations, filled capsules and medicinal compounds in solid and liquid form for the treatment of diabetes, diarrhea, fungal infections/conditions, hypertension, inflammation, arthritis, helminth infections, cardiovascular conditions, allergies, dermatological conditions, gynaecological conditions, haematological conditions, metabolic conditions, nausea and vertigo, oncological diseases and disorders, cancer and tumours; biopharmaceuticals for medical and veterinary use, namely, biopharmaceutical preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; enzymes for medical purposes; enzymes for veterinary purposes; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; antibodies for medical purposes; antibody-drug conjugates in the nature of antibodies for medical purposes; proteins for medical purposes, namely, for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being protein based; nucleic acid sequences for medical and veterinary purposes; peptides for medical and veterinary purposes, namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being peptide based; polypeptides containing non-proteinogenic amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-proteinogenic amino acid polypeptide based; polypeptides containing non-canonical amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-canonical amino acid polypeptide based
Class 040
Biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of hydroxy acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids and hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids and hydroxy acids
Class 042
Scientific research relating to medicines; scientific research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; scientific research and development for the pharmaceutical industry; scientific research and development in the field of biomaterials; scientific design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research in the field of DNA synthesis; scientific research in the field of protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; research in the field of bioinformatics relating to design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research relating to genetic code expansion
Classification
International Classes
001
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIO